Research record

Berberine Derivative B68 Promotes Tumor Immune Clearance by Dual-Targeting BMI1 for Senescence Induction and CSN5 for PD-L1 Degradation.

Research record published by Advanced science (Weinheim, Baden-Wurttemberg, Germany), indexed because it matched monitored longevity research terms. Inclusion in this index does not establish that an intervention is effective or safe.

Plain-language guide

Five questions to ask about this record

What this is
research-record record from Advanced science (Weinheim, Baden-Wurttemberg, Germany).
Why it may matter
It matched a longevity topic and may show how that evidence area is developing.
Evidence
Automated topic match 100%; this is not a medical rating.
Main limitation
One research record does not prove safety, effectiveness, or usefulness for an individual.
What changed
Source metadata was published or refreshed December 25, 2024.
Where to verify
Open the primary source below for methods, population, results, and limitations.
Published
December 25, 2024
Journal
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Authors
Hongmei Hu, Qun Wang, Dianping Yu, Xiaoyu Tao, Mengmeng Guo, Saisai Tian, Qing Zhang, Mengting Xu, Xiangxin Geng, Hongwei Zhang, Hanchi Xu, Linyang Li, Shize Xie, Kaixian Chen, Weiliang Zhu, Xu-Wen Li, Hanchen Xu, Bo Li, Weidong Zhang, Sanhong Liu
DOI
10.1002/advs.202413122
Evidence class
research-record
Record status
published
Match confidence
100%
Source feed
PubMed
Automated source synopsis

Research record published by Advanced science (Weinheim, Baden-Wurttemberg, Germany), indexed because it matched monitored longevity research terms. Inclusion in this index does not establish that an intervention is effective or safe.

Evidence snapshot

What the source actually supports

Evidence stage
Research record
Study design
Journal Article
Evidence population
Not reported in reusable metadata
Participants
Not reported
Population
Not reported
Duration
Not reported
Intervention
Comparator
Not reported
Outcomes measured
Reported result
No reusable finding-level result is available in this record.

Main limitationBibliographic metadata identifies the record but does not provide enough reusable detail to summarize its population, comparison, findings, or effect size.

Safety and approvalThis index record does not establish safety, effectiveness, dose, or suitability for any person. A publication record is not a regulatory approval or treatment recommendation.

Source supportBibliographic citation metadata and controlled indexing terms only. Read the linked source for methods and results.

Evidence stage · research-recordThis describes the study type, not whether an intervention is safe or effective.
Lab or animalHuman studyRandomized trialEvidence synthesis
Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Cancer and ageing · 100%Title contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.
  • Senolytics · 65%Source terminology contains a controlled topic term. Title supplies ageing or longevity context.

Automated source check 95% · update recency 65%. These figures help sort records; they are not medical ratings.

BibTeX · RIS

cancer and agingsenolytics
Read the original source →Export JSON